Odds ratios (OR) can overestimate risk when the prevalence of outcomes is more than 10%. We compared logistic and modified Poisson models in 5843 National Alzheimer's Coordinating Center decedents to examine associations of apolipoprotein (APOE) ε4, age at death, sex, and education with 7 neuropathologies. OR for neuritic plaques (6.28) and Braak stage (4.90) attenuated to prevalence rate ratios of 1.38 and 1.08; similar attenuation occurred for Lewy body disease, arteriolosclerosis, cerebral amyloid angiopathy, and infarcts. Modified Poisson regression is critical for valid risk estimation, reliable interpretations, and accurate risk stratification in non-rare outcome studies.
BoylePAYuLNagS, et al.Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology2015; 85: 1930–1936.
2.
JamesBDWilsonRSBoylePA, et al.TDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia. Brain2016; 139: 2983–2993.
3.
NagSYuLCapuanoAW, et al.Hippocampal sclerosis and TDP -43 pathology in aging and A lzheimer disease. Ann Neurol2015; 77: 942–952.
4.
SchneiderJAArvanitakisZYuL, et al.Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain2012; 135: 3005–3014.
5.
ZhangJYuKF. What’s the relative risk?: a method of correcting the odds ratio in cohort studies of common outcomes. JAMA1998; 280: 1690.
6.
NaimiAIWhitcombBW. Estimating risk ratios and risk differences using regression. Am J Epidemiol2020; 189: 508–510.
7.
ZouG. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol2004; 159: 702–706.
8.
AgrawalSYuLKapasiA, et al.Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons. Brain Pathol2021; 31: e12939.
9.
AgrawalSYuLNagS, et al.The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer’s dementia in older persons. Acta Neuropathol Commun2021; 9: 156.
HayesCAThorpeRJOddenMC. Age-dependent interactions of APOE isoform 4 and Alzheimer’s disease neuropathology: findings from the NACC. Acta Neuropathol Commun2025; 13: 102.
12.
HymanBTPhelpsCHBeachTG, et al.National institute on aging–Alzheimer’s association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement2012; 8: 1–13.
13.
MontineTJPhelpsCHBeachTG, et al.National institute on aging–Alzheimer’s association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol (Berl)2012; 123: 1–11.
14.
RymanSGYutsisMTianL, et al.Cognition at each stage of Lewy body disease with co-occurring Alzheimer’s disease pathology. J Alzheimers Dis2021; 80: 1243–1256.
15.
LovasiGSUnderhillLJJackD, et al.At odds: concerns raised by using odds ratios for continuous or common dichotomous outcomes in research on physical activity and obesity. Open Epidemiol J2012; 5: 13–17.
16.
McNuttL-A. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol2003; 157: 940–943.
17.
ThorpeRJCobbRKingK, et al.The association between depressive symptoms and accumulation of stress among black men in the health and retirement study. Innov Aging2020; 4: igaa047.
18.
LamarMYuLRubinLH, et al.APOE Genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimers Dement2019; 15: 258–266.
19.
DicksonDWHeckmanMGMurrayME, et al.APOE Ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology2018; 91: e1182–e1195.
